Literature DB >> 25505264

LDL receptor and ApoE are involved in the clearance of ApoM-associated sphingosine 1-phosphate.

Makoto Kurano1, Kazuhisa Tsukamoto2, Masumi Hara3, Ryunosuke Ohkawa4, Hitoshi Ikeda5, Yutaka Yatomi6.   

Abstract

Sphingosine 1-phosphate (S1P) is a vasoactive lipid mediator that is speculated to be involved in various aspects of atherosclerosis. About 70% of circulating plasma S1P is carried on HDL, and several pleiotropic properties of HDL have been ascribed to S1P. In the previous study with human subjects, however, LDL cholesterol or apoB, but not HDL cholesterol or apoA-I, had a significant positive correlation with the plasma S1P level, suggesting that the metabolic pathway for LDL might have some roles in the metabolism of S1P. In this study, we analyzed the association between LDL receptor, an important protein in the clearance of LDL, and circulating S1P. We observed that in LDL receptor-overexpressing mice, the plasma S1P levels as well as apolipoprotein M (apoM), a carrier of S1P, were decreased and that exogenously administered C17S1P bound to apoM-containing lipoproteins was cleared more rapidly. Unlike the situation in wild-type mice, LDL receptor overexpression in apoE-deficient mice did not reduce the plasma S1P or apoM levels, suggesting that apoE might be a ligand for the LDL receptor during the clearance of these factors. The present findings clarify the novel roles of the LDL receptor and apoE in the clearance of S1P, a multifunctional bioactive phospholipid.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Apolipoprotein; Apolipoprotein E (ApoE); Lipoprotein Receptor; Low-density Lipoprotein (LDL); Sphingosine 1-Phosphate (S1P)

Mesh:

Substances:

Year:  2014        PMID: 25505264      PMCID: PMC4303696          DOI: 10.1074/jbc.M114.596445

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

Review 1.  Structural and functional characteristics of S1P receptors.

Authors:  Teresa Sanchez; Timothy Hla
Journal:  J Cell Biochem       Date:  2004-08-01       Impact factor: 4.429

Review 2.  Pleiotypic mechanisms of cellular responses to biologically active lysophospholipids.

Authors:  E J Goetzl
Journal:  Prostaglandins Other Lipid Mediat       Date:  2001-04       Impact factor: 3.072

Review 3.  High-density lipoprotein cholesterol raising: does it matter?

Authors:  Jonathan D Schofield; Michael France; Basil Ammori; Yifen Liu; Handrean Soran
Journal:  Curr Opin Cardiol       Date:  2013-07       Impact factor: 2.161

Review 4.  Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges.

Authors:  Uchechukwu K Sampson; Sergio Fazio; MacRae F Linton
Journal:  Curr Atheroscler Rep       Date:  2012-02       Impact factor: 5.113

5.  Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M.

Authors:  Christina Christoffersen; Hideru Obinata; Sunil B Kumaraswamy; Sylvain Galvani; Josefin Ahnström; Madhumati Sevvana; Claudia Egerer-Sieber; Yves A Muller; Timothy Hla; Lars B Nielsen; Björn Dahlbäck
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-23       Impact factor: 11.205

Review 6.  Clinical review: The evolving role of HDL in the treatment of high-risk patients with cardiovascular disease.

Authors:  H Bryan Brewer
Journal:  J Clin Endocrinol Metab       Date:  2011-03-09       Impact factor: 5.958

Review 7.  Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases.

Authors:  Y Yatomi
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

8.  An ELISA for apolipoprotein M reveals a strong correlation to total cholesterol in human plasma.

Authors:  Olof Axler; Josefin Ahnström; Björn Dahlbäck
Journal:  J Lipid Res       Date:  2007-05-25       Impact factor: 5.922

Review 9.  Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator?

Authors:  Fumikazu Okajima
Journal:  Biochim Biophys Acta       Date:  2002-05-23

10.  Plasma sphingosine-1-phosphate is elevated in obesity.

Authors:  Greg M Kowalski; Andrew L Carey; Ahrathy Selathurai; Bronwyn A Kingwell; Clinton R Bruce
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

View more
  17 in total

Review 1.  Sphingosine kinase and sphingosine-1-phosphate in liver pathobiology.

Authors:  Timothy Rohrbach; Michael Maceyka; Sarah Spiegel
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-06-15       Impact factor: 8.250

2.  Upregulated Sphingosine 1-Phosphate Receptor 1 Expression in Human and Murine Atherosclerotic Plaques.

Authors:  Hui Liu; Hongjun Jin; Junbin Han; Xuyi Yue; Hao Yang; Mohamed A Zayed; Robert J Gropler; Zhude Tu
Journal:  Mol Imaging Biol       Date:  2018-06       Impact factor: 3.488

Review 3.  Implications of Sphingolipids on Aging and Age-Related Diseases.

Authors:  Shengxin Li; Hyun-Eui Kim
Journal:  Front Aging       Date:  2022-03-03

4.  A novel approach for measuring sphingosine-1-phosphate and lysophosphatidic acid binding to carrier proteins using monoclonal antibodies and the Kinetic Exclusion Assay.

Authors:  Jonathan K Fleming; Thomas R Glass; Steve J Lackie; Jonathan M Wojciak
Journal:  J Lipid Res       Date:  2016-07-21       Impact factor: 5.922

5.  Resveratrol exerts a biphasic effect on apolipoprotein M.

Authors:  Makoto Kurano; Masumi Hara; Takahiro Nojiri; Hitoshi Ikeda; Kazuhisa Tsukamoto; Yutaka Yatomi
Journal:  Br J Pharmacol       Date:  2015-11-12       Impact factor: 8.739

6.  Apolipoprotein M promotes cholesterol uptake and efflux from mouse macrophages.

Authors:  Shuang Yao; Fan Zheng; Yang Yu; Yuxia Zhan; Ning Xu; Guanghua Luo; Lu Zheng
Journal:  FEBS Open Bio       Date:  2021-05-02       Impact factor: 2.693

7.  Effects of hyperlipidaemia on plasma apolipoprotein M levels in patients with type 2 diabetes mellitus: an independent case-control study.

Authors:  Puhong Zhang; Jialin Gao; Chun Pu; Gang Feng; Lizhuo Wang; Lizhu Huang; Qingsong Tao; Yao Zhang
Journal:  Lipids Health Dis       Date:  2016-09-15       Impact factor: 3.876

8.  Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons.

Authors:  Cecilia Frej; Adam Linder; Kaisa E Happonen; Fletcher B Taylor; Florea Lupu; Björn Dahlbäck
Journal:  J Cell Mol Med       Date:  2016-03-17       Impact factor: 5.310

9.  Glycation of HDL Polymerizes Apolipoprotein M and Attenuates Its Capacity to Bind to Sphingosine 1-Phosphate.

Authors:  Tamaki Kobayashi; Makoto Kurano; Mai Nanya; Tomo Shimizu; Ryunosuke Ohkawa; Minoru Tozuka; Yutaka Yatomi
Journal:  J Atheroscler Thromb       Date:  2021-01-29       Impact factor: 4.928

10.  Inhibition of S1P Receptor 2 Attenuates Endothelial Dysfunction and Inhibits Atherogenesis in Apolipoprotein E-Deficient Mice.

Authors:  Byambasuren Ganbaatar; Daiju Fukuda; Masakazu Shinohara; Shusuke Yagi; Kenya Kusunose; Hirotsugu Yamada; Takeshi Soeki; Ken-Ichi Hirata; Masataka Sata
Journal:  J Atheroscler Thromb       Date:  2020-09-02       Impact factor: 4.928

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.